Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles BMC Women's Health Year : 2010

Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment

Dominique Huas
  • Function : Author
  • PersonId : 919176
Françoise Debiais
  • Function : Author
  • PersonId : 919177
Francis Blotman
  • Function : Author
  • PersonId : 919178
Bernard Cortet
  • Function : Author
  • PersonId : 919179
Florence Mercier
  • Function : Author
  • PersonId : 919180
Chantal Rousseaux
  • Function : Author
  • PersonId : 919181
Véronique Berger
  • Function : Author
  • PersonId : 919182

Abstract

Background
Adherence to anti-osteoporosis treatments is poor, exposing treated women to increased fracture risk. Determinants of poor adherence are poorly understood. The study aims to determine physician- and patient- rated treatment compliance with osteoporosis treatments and to evaluate factors influencing compliance.
Methods
This was an observational, cross-sectional pharmacoepidemiological study with a randomly-selected sample of 420 GPs, 154 rheumatologists and 110 gynaecologists practicing in France. Investigators included post-menopausal women with a diagnosis of osteoporosis and a treatment initiated in the previous six months. Investigators completed a questionnaire on clinical features, treatments and medical history, and on patient compliance. Patients completed a questionnaire on sociodemographic features, lifestyle, attitudes and knowledge about osteoporosis, treatment compliance, treatment satisfaction and quality of life. Treatment compliance was evaluated with the Morisky Medication-taking Adherence Scale. Variables collected in the questionnaires were evaluated for association with compliance using multivariate logistic regression analysis.
Results
785 women were evaluated. Physicians considered 95.4% of the sample to be compliant, but only 65.5% of women considered themselves compliant. The correlation between patient and physician perceptions of compliance was low (κ: 0.11 [95% CI: 0.06 to 0.16]). Patient-rated compliance was highest for monthly bisphosphonates (79.7%) and lowest for hormone substitution therapy (50.0%). Six variables were associated with compliance: treatment administration frequency, perceptions of long-term treatment acceptability, perceptions of health consequences of osteoporosis, perceptions of knowledge about osteoporosis, exercise and mental quality of life.
Conclusion
Compliance to anti-osteoporosis treatments is poor. Reduction of dosing regimen frequency and patient education may be useful ways of improving compliance.
Fichier principal
Vignette du fichier
1472-6874-10-26.pdf (225.37 Ko) Télécharger le fichier
1472-6874-10-26-S1.PDF (22.88 Ko) Télécharger le fichier
1472-6874-10-26-S2.PDF (59.03 Ko) Télécharger le fichier
1472-6874-10-26.xml (67.63 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other
Format : Other
Format : Other

Dates and versions

inserm-00663888 , version 1 (27-01-2012)

Identifiers

Cite

Dominique Huas, Françoise Debiais, Francis Blotman, Bernard Cortet, Florence Mercier, et al.. Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment. BMC Women's Health, 2010, 10 (1), pp.26. ⟨10.1186/1472-6874-10-26⟩. ⟨inserm-00663888⟩
209 View
18377 Download

Altmetric

Share

Gmail Facebook X LinkedIn More